NewYork-Presbyterian/Columbia University Medical Center has named Gary Schwartz, MD, Chief of the Division of Hematology/Oncology in the Department of Medicine and Associate Director for Research of its Herbert Irving Comprehensive Cancer Center. Dr. Schwartz assumed his new role on January 1, 2014.
At the Herbert Irving Comprehensive Cancer Center, Dr. Schwartz will lead the expansion of clinical research and patient care, with a focus on building a comprehensive team of physicians and scientists to conduct research on the full spectrum of cancers and to bring the resulting advances to patients. He also will continue his research on improving ways to treat melanoma, sarcoma, and cancers of the gastrointestinal tract, his areas of expertise and clinical specialty.
Background in Translational and Clinical Research
“We are very excited to welcome Dr. Schwartz,” said Stephen Emerson, MD, Director of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia and the Clyde and Helen Wu Professor of Immunology (in Medicine) and Professor of Microbiology and Immunology at Columbia University Medical Center. “He brings an unparalleled background in translational and clinical research, including the development and testing of new anticancer drugs.
Compassion and Commitment
“Patients will benefit greatly from Dr. Schwartz’s expertise, not only in the treatment of melanoma, sarcoma, and cancers of the gastrointestinal tract, but also a wide variety of solid tumors and hematologic malignancies, through his focus on novel agents with activity against fundamental mechanisms of cancer,” said Donald W. Landry, MD, Physician-in-Chief at NewYork-Presbyterian/Columbia and the Samuel Bard Professor of Medicine and Chair of the Department of Medicine at Columbia University Medical Center. “Further, he brings a keen sense of compassion and commitment to patient-centered practice, personifying all that we strive for in clinical care at NewYork-Presbyterian/Columbia.”
Dr. Schwartz joins NewYork-Presbyterian/Columbia from Memorial Sloan-Kettering Cancer Center, where he was Chief of the Melanoma and Sarcoma Service. Dr. Schwartz completed his residency at North Shore University Hospital and a fellowship at Mount Sinai School of Medicine in New York. ■